Clinical Trials Shed Light on the Hidden Harm of Taking Antidepressants

Photo of author

( — February 3, 2021) Orlando, FL — Antidepressants are widely used nowadays, especially that the rates of depression continue to skyrocket. It is important to realize that depression continues to happen to more and more people. 

Statistics reveal that depression affects around 3.8 percent of the global population. It is not just alarming because it is highly prevalent, but also of the fact that 25 percent of those that have it are admitted to hospitals due to psychotic depression. 

Further, its overall economic burden is $210.5 billion. Reports further show that 35 percent of adults with a major depressive episode are unable to get treatment. It is also important to stress that it is the top cause of disability worldwide. 

Depression is also most likely to happen in young adults aged 18 to 22 years. 

An in-depth analysis of clinical trials reveals widespread underreporting of negative side effects, including suicide attempts and aggressive behavior

According to the 2011 report by the National Center for Health Statistics, more than one out of 10 Americans over age 12—roughly 11 percent—take these drugs.

It is further worth mentioning that recent reports reveal essential data regarding the safety of these medications, especially their risk for children and adolescents. 

A study was published in the British Medical Journal (BMJ). 

This study was carried out by a group of researchers at the Nordic Cochrane Center in Copenhagen.

The findings of this research suggest pharmaceutical companies were not presenting the full extent of serious harm in clinical study reports.

It is worth mentioning the clinical study reports pertain to detailed documents sent to regulatory authorities, such as the U.S. Food and Drug Administration and the European Medicines Agency (EMA), when applying for approval of a new drug. 

Some of the alarming side effects of using these medications are suicidal attempts and worsening of depression.

More studies are actually still being carried out to explore more of the ways to ward off depression and reduce the need to use antidepressants.

In an attempt to decrease the prevalence of depression, more and more experts are looking into the potentially helpful remedies for this brain health issue. 

Interestingly, some studies have found probiotics may help. Some of the most popular probiotic foods are kimchi or yogurt, but they can also be obtained via supplementation. 

Scientists have long been suggesting that there is a connection between the gut and the brain. Due to the positive effects of probiotics in digestive health, they have been theorized to be helpful for mental health. 

Researchers are increasingly looking into the effects of a special group of probiotics called psychobiotics, which are theorized to fight depression and boost overall mood.

Their depression-fighting, medicinal effects may be obtained through the use of formulas like Divine Bounty Digestive Enzymes.

Divine Bounty Digestive Enzymes contain 500 mg of digestive enzymes, namely lipase, amylase, invertase, Glucoamylase, papain, and bromelain. It even has prebiotics, and probiotics.

For every bottle, it offers 90 Vegetarian highly potent and pure capsules (

About Divine Bounty

Divine Bounty is a family-owned brand that manufactures high-quality turmeric curcumin supplements. Passionate about the potential health benefits of turmeric, the team behind Divine Bounty have carefully researched and sourced only the best ingredients to create the ideal blend of turmeric curcumin. More details are available at

Divine Bounty

12001 Research Parkway
Suite 236 A
Orlando, FL 32826
United States